Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print RSS Feed

Breaking News

Related Searches: Financial Reports •
Genzyme 3Q

October 24, 2007
Genzyme Corp. 3Q Revenues: $960 million (+19%) 3Q Earnings: $159 million (up from $16 million in 3Q06) YTD Revenues: $2.8 billion (+19%) YTD Earnings: $401 million (+60%) Comments: Myzozyme sales rose 162% to $54 million in 3Q07, and t…  Read More »
GlaxoSmithKline 3Q

October 24, 2007
GlaxoSmithKline 3Q Revenues: $11.1 billion (+5% in USD, -3% in local currency) 3Q Earnings: $2.7 billion (+2% in USD, -6% in local currency) YTD Revenues: $33.3 billion (+6% in USD, -3% in local currency) YTD Earnings: $8.4 billion (+8% i…  Read More »
Almac Invests $100 million in NA HQ

October 23, 2007
Almac, a provider of R&D and manufacturing services based in Craigavon, Northern Ireland, announced plans to invest $100 million to build its North American headquarters. The new facility will add approximately 260 jobs within three years. Sai…  Read More »
GSK, Tolerx Collaborate on Anti-CD3 MAb

October 23, 2007
GlaxoSmithKline and Tolerx, Inc. have formed a worldwide alliance to develop and commercialize otelixizumab (TRX4), a novel humanized anti-CD3 monoclonal antibody that has potential across a broad range of autoimmune and immune-mediated inflammatory…  Read More »
Biogen Idec 3Q

October 23, 2007
Biogen Idec 3Q Revenues: $789 million (+12%) 3Q Earnings: $119 million (-24%) YTD Revenues: $2.3 billion (+15%) YTD Earnings: $437 million (+301%) Comments: Avonex sales leveled off, up 2% to $455 million, while BI's share of Rituxan r…  Read More »
Merck 3Q

October 22, 2007
Merck 3Q Revenues: $6.1 billion (+12%) 3Q Earnings: $1.5 billion (+62%) YTD Revenues: $18.0 billion (+8%) YTD Earnings: $4.9 billion (+24%) Comments: Singulair sales rose 17% to $1 billion. Diabetes treatment Januvia, launched in Octob…  Read More »
Schering-Plough 3Q

October 22, 2007
Schering-Plough 3Q Revenues: $2.8 billion (+9%) 3Q Earnings: $750 million (+142%) YTD Revenues: $9.0 billion (+13%) YTD Earnings: $1.9 billion (+97%) Comments: Revenues do not reflect sales of Vytorin and Zetia, which are accounted as…  Read More »
Phase II TRA Results for Schering-Plough

October 22, 2007
Schering-Plough released not-bad news about its novel oral thrombin receptor antagonist (TRA), as two Phase II studies in patients with vascular disease showed that TRA does not increase the rate of major or minor bleeding in patients with acute coro…  Read More »
Gilead Sciences 3Q

October 19, 2007
Gilead Sciences 3Q Revenues: $1.1 billion (+41%) 3Q Earnings: $398 million (net loss of $52 million in 3Q06) YTD Revenues: $3.1 billion (+47%) YTD Earnings: $1.2 billion (+155%) Comments: Sales of new HIV medication Atripla reached $24…  Read More »
King Pharma Changes Strategy, Lays Off 20%

October 19, 2007
King Pharmaceuticals plans to lay off 20% of its workforce in an effort to speed up its strategic focus in neuroscience and hospital/acute care. The company estimates that the firings and other reductions in general and administrative expenses will s…  Read More »
Pfizer 3Q

October 18, 2007
Pfizer 3Q Revenues: $12.0 billion (-2%) 3Q Earnings: $761 million (-77%) YTD Revenues: $35.6 billion (-1%) YTD Earnings: $5.4 billion (-45%) Comments: 3Q Pharma sales dropped 4% to $11.0 billion. Ongoing generic erosion from Zoloft (Ju…  Read More »
Wyeth 3Q

October 18, 2007
Wyeth 3Q Revenues: $5.6 billion (+9%) 3Q Earnings: $1.1 billion (flat) YTD Revenues: $16.6 billion (+10%) YTD Earnings: $3.6 billion (+8%) Comments: 3Q pharma revenues were up 10% to $4.7 billion, driven by a 24% boost in sales of Prev…  Read More »
Novartis 3Q

October 18, 2007
Novartis 3Q Revenues: $9.6 billion (+9%) 3Q Earnings: $6.8 billion (+267%) YTD Revenues: $28.1 billion (+13%) YTD Earnings: $11.0 billion (+100%) Comments: Net earnings included $5.2 billion from the sale of the Medical Nutrition and G…  Read More »
Ricerca Biosciences

October 17, 2007
Ricerca Biosciences has named James R. Szabo, D.V.M., Ph.D., DACVP, to the role of vice president - Biology Services. In this capacity Dr. Szabo will oversee the new primate facility under construction at Ricerca as well as direct the day-to-day oper…  Read More »
ImClone, BMS, Merck KgA Collaborate in Japan

October 17, 2007
ImClone and Bristol-Myers Squibb have established an agreement with Merck KgA to co-develop and co-commercialize Erbitux in Japan. The three companies will collaborate on a joint effort to develop and, following regulatory approval, market the drug i…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: